Our Studies | Healix

A 3-Year Evaluation of Antibiotic Resistance Patterns in Gram-Negative Genitourinary Tract Infections Treated in Outpatient Infusion Centers (POICs)

March 1, 2022

Successful Early Discharge and Avoided Hospitalization for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Treated with Outpatient Parenteral Antimicrobial Therapy (OPAT) Result in Healthcare Cost Savings

March 3, 2020

A 2-Year Analysis of 30-Day Hospital Readmissions and Cost Benefits of Septicemia Outpatient Treatment in a Physician Office Infusion Center (POIC)

March 3, 2020

Comparison of Outpatient Antimicrobial Therapy (OPAT) in a Physician Office Infusion Center (POIC) vs. Traditional Home Health Care (HHC)

March 3, 2020

Cost Savings Utilizing Outpatient Parenteral Antimicrobial Therapy (OPAT) for Treatment of Complicated Skin and Skin Structure Infections (cSSSI) in Physician Operated Infusion Centers (POICs) without Hospitalization

March 3, 2020

Publication: Outpatient Treatment of Osteomyelitis with Telavancin

March 3, 2020

Outpatient Treatment of Infective Endocarditis at Physician Office Infusion Centers (POICs): A 2-Year Analysis of Clinical and Economic Outcomes

March 3, 2020

Real-World Comparison of Arthralgias with Infliximab vs. Vedolizumab in the Treatment of Bio-Naïve Inflammatory Bowel Disease

March 3, 2020

Outpatient Treatment and Recurrence of Prosthetic Joint Infection (PJI) Treated in Infectious Disease (ID) Physician Office Infusion Centers (POICs): A 2-Year Retrospective Multicenter Analysis

March 3, 2020

Real-World Experience of Vedolizumab in Pediatric Inflammatory Bowel Disease

March 3, 2020

Safety and Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Aged Population

March 3, 2020

Tolerability and Persistence with Subcutaneous Immunoglobulin Provided Through Physician Clinics for the Treatment of Primary Immunodeficiencies

March 3, 2020

Effective Antimicrobial Stewardship for Outpatient Antimicrobial Therapy (OPAT): Nationwide Experience in Infectious Diseases Physician Infusion Centers

March 3, 2020

Evaluation of Bezlotoxumab in Prevention of Recurrent C. Difficile Infection: A multicenter Single-Arm Study in Office Infusion Centers

March 3, 2020

Healthcare Resource Utilization for High-Risk Patients Treated with Dalbavancin in Physician Office Infusion Centers

March 3, 2020

Predictors of Vedolizumab Treatment Persistence in Bio-Naïve Ulcerative Colitis Patients

February 12, 2020

Real-World Prescribing Patterns of Certolizumab in the Treatment of Crohn’s Disease

December 12, 2019

Long-Term Efficacy of Vedolizumab in Pediatric Inflammatory Bowel Disease

October 25, 2019

Onset of Response with Infliximab vs. Vedolizumab in the Treatment of Bio-Naïve Inflammatory Bowel Disease

October 25, 2019

Second-Line Biologic Therapy After Vedolizumab

October 25, 2019

Use of Ustekinumab in Pediatric Crohn’s Disease – A Report of Three Cases

October 25, 2019

Response and Healthcare Resource Utilization in Inflammatory Bowel Disease Patients Treated with Either Infliximab or Vedolizumab

October 25, 2019

Low 30-Day Hospital Readmission Rates in Medicare Patients Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers

October 2, 2019

Serious Bacterial Infections: Successful Outpatient Management by Infectious Disease Physicians in Office Infusion Centers

October 2, 2019

Recurrent Clostridioides Difficile Infection (CDI) Worsens Anxiety-Related Patient-Reported Quality of Life

October 2, 2019

Real-World Use of Ibalizumab in Physician Office infusion Centers (POICs)

October 2, 2019

Application of Bayesian Modeling with Infliximab to Determine Optimal Patient Specific Regimen

May 18, 2019

Tolerability and Persistence with Subcutaneous Immunoglobulin Provided Through Physician Clinics for the Treatment of Primary Immunodeficiencies

February 22, 2019

Failure of Vedolizumab as First Line Biologic Does Not Decrease Response Rate of Second Line Therapy

October 5, 2018

Therapeutic Drug Monitoring of Biologics in patients with Inflammatory Bowel Disease: A Real-World Experience

October 5, 2018

Mandated Payor Switching with Infliximab (IFX) Bioimilars

October 5, 2018

Healthcare Resource Utilization in Inflammatory Bowel Disease Patients: A 2-Year Analysis

October 5, 2018

Infection Incidence and Utilization of Antimicrobials in Physician Office Infusion Centers (POICs)

October 3, 2018

Real World Experience of Bezlotoxumab for Prevention of Recurrent C. Difficile Infection: A Single-Arm Multicenter Pilot Study in Office Infusion Centers

June 2, 2018

Real World Evaluation of Prolonged Clinical Response with Vedolizumab in Crohn’s Disease and Ulcerative Colitis patients Treated in a Private Practice Setting

January 18, 2018

Long-Term Safety Analysis of Vedolizumab for Treatment of Crohn’s Disease and Ulcerative Colitis

October 13, 2017

Can Vedolizumab Non-Responders Be Treated Successfully with Another Biologic Agent?

October 13, 2017

Successful Establishment of an Antimicrobial Stewardship Program (ASP) for Outpatient Parenteral Antimicrobial Therapy (OPAT)

October 4, 2017

Clinical and Economic Outcomes of Outpatient Parenteral Antimicrobial Therapy (OPAT) Among Indigent Patients: A Retrospective Multicenter Analysis

June 26, 2017

Outpatient Treatment of Infective Endocarditis (IE) at Physician Office Infusion Centers (POICs): A 2-Year Analysis of Clinical and Economic Outcomes

October 26, 2016

Ceftolozane/Tazobactam: Outpatient Treatment of Gram-Negative Infections at Physician Office Infusion Centers (POICs)

October 26, 2016

Successful Early Discharge and Avoided Hospitalization for Methicillin-Resistant Staphylococcus aureus Infections Treated With Outpatient Parenteral Antimicrobial Therapy Result in Healthcare Cost Savings

October 24, 2016

Successful Management of Osteomyelitis in Infectious Disease Physician Office Infusion Centers (POICs)

October 7, 2015

Antimicrobial Regimen and Safety of Pediatric Outpatient Treatment in a Physician Office Infusion Center (POIC)

October 7, 2015

Antimicrobial Regimen and Safety of Pediatric Outpatient Treatment in a Physician Office Infusion Center (POIC)

October 7, 2015

Dalbavancin: A Nationwide Outpatient Experience in Physician Office Infusion Centers (POICs)

October 7, 2015

Low Hospital Admission Rates Following Physician Office Infusion Center (POIC)-Based Outpatient Treatment with Intravenous Antibiotics

October 8, 2014

Outpatient Parenteral Antimicrobial Therapy (OPAT) for Treatment of Complicated Intra-Abdominal Infections

October 2, 2013

Vancomycin Experience in Physician Office Infusion Centers

October 2, 2013

Clinical Success in Outpatient Treatment of Complicated Urinary Tract Infections (UTI) with Ertapenem

October 2, 2013

Clostridium difficile-Associated Diarrhea Incidence and Outcomes for Patients Treated with Intravenous Antibiotics in Infectious Disease Physician Office Infusion Centers (POICs)

October 17, 2012

Comparison of Outcomes and Costs in Patients with Urinary Tract Infections (UTI) or Pneumonia (PNA) with Treatment Initiated in a Physician Office Infusion Center (POIC) versus Those Treated After Hospital Discharge

October 17, 2012

Utilization of Intravenous Antimicrobials over a One-Year Period in Physician Office Infusion Centers (POICs)

October 17, 2012

Successful, Cost-Saving Outpatient Parenteral Antimicrobial Therapy (OPAT) Following Hospital Discharge: Early Pilot Study of an Indigent Healthcare Program between a Physician Office Infusion Center (POIC) and Two Tucson Hospitals

October 17, 2012

Outcomes Comparison of Intravenous Antimicrobials Provided in a Physician Office Infusion Center (POIC) versus Traditional Home Care (HC) Services

October 17, 2012

Incidence of Central Venous Catheter (CVC) Infections in Patients Treated with Intravenous Antibiotics (IVAB) in the Physician Office Infusion Center (POIC)

October 16, 2012

Outcomes and Readmissions of Bacteremia, Endocarditis and Osteomyelitis among Patients Treated with Outpatient Parenteral Antimicrobial Therapy (OPAT) in Infectious Disease Physician Office Infusion Centers (POIC)

October 20, 2011

Clostridium difficile Associated Diarrhea Incidence and Outcomes for Patients Treated with Intravenous Antibiotics in Infectious Disease Physician Office Infusion Centers

October 20, 2011

Successful, Cost-Saving OPAT Therapy Initiated in a Physician Office Infusion Center (POIC) for Treatment of Osteomyelitis and Complicated Skin and Skin Structure Infections, a 3-Year Analysis

October 20, 2011

Outpatient Parenteral Antibiotic Therapy (OPAT) with Telavancin: A Multi-Center Experience

October 20, 2011

Clinical Success Demonstrated in Treatment of Complicated Genitourinary Gram Negative Infections in a Physician Office Infusion Center (POIC)

October 21, 2010

Successful Treatment of Complicated Gram Negative Sinopulmonary Infections Treated in Infectious Disease (ID) Physician Office Infusion Centers (POICs)

October 21, 2010

Infection Control Enhancements through Successful Implementation of United States Pharmacopeia Chapter <797> Standards (USP 797) in a Physician Infusion Center Pharmacy

October 21, 2010

Safety, Efficacy and Cost-Benefit of Initiating Treatment of Osteomyelitis and Complicated Skin and Skin Structure Infections in a Physician Office-Based Infusion Center, A Two-Year Review

October 21, 2010

Treatment of Osteomyelitis in Infectious Disease Physician-Operated Infusion Centers (POICs)

October 29, 2009

Safety and Efficacy of Direct Physician Office-Based Infusion Center (POIC) Admissions for Antibiotic Treatment of Osteomyelitis (OSTEO) and Complicated Skin and Skin Structure Infections (cSSSI)

October 29, 2009

Parenteral Antimicrobial Therapy Initiated in the Infectious Disease (ID) Physician Office: What and Why?

October 10, 2009

Comparison of Outpatient Antibiotic Therapy (OPAT) Use of Daptomycin, Linezolid, Quinupristin/Dalfopristin, Tigecycline, and Vancomycin in Physician-Operated Infusion Centers (POICs)

October 25, 2008

A 3-Year Evaluation of Antibiotic Resistance Patterns in Gram-Negative Genitourinary Tract Infections Treated in Outpatient Infusion Centers (POICs)

Successful Early Discharge and Avoided Hospitalization for Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Treated with Outpatient Parenteral Antimicrobial Therapy (OPAT) Result in Healthcare Cost Savings

A 2-Year Analysis of 30-Day Hospital Readmissions and Cost Benefits of Septicemia Outpatient Treatment in a Physician Office Infusion Center (POIC)

Comparison of Outpatient Antimicrobial Therapy (OPAT) in a Physician Office Infusion Center (POIC) vs. Traditional Home Health Care (HHC)

Cost Savings Utilizing Outpatient Parenteral Antimicrobial Therapy (OPAT) for Treatment of Complicated Skin and Skin Structure Infections (cSSSI) in Physician Operated Infusion Centers (POICs) without Hospitalization

Publication: Outpatient Treatment of Osteomyelitis with Telavancin

Outpatient Treatment of Infective Endocarditis at Physician Office Infusion Centers (POICs): A 2-Year Analysis of Clinical and Economic Outcomes

Real-World Comparison of Arthralgias with Infliximab vs. Vedolizumab in the Treatment of Bio-Naïve Inflammatory Bowel Disease

Outpatient Treatment and Recurrence of Prosthetic Joint Infection (PJI) Treated in Infectious Disease (ID) Physician Office Infusion Centers (POICs): A 2-Year Retrospective Multicenter Analysis

Real-World Experience of Vedolizumab in Pediatric Inflammatory Bowel Disease

Safety and Effectiveness of Outpatient Parenteral Antimicrobial Therapy (OPAT) in the Aged Population

Tolerability and Persistence with Subcutaneous Immunoglobulin Provided Through Physician Clinics for the Treatment of Primary Immunodeficiencies

Effective Antimicrobial Stewardship for Outpatient Antimicrobial Therapy (OPAT): Nationwide Experience in Infectious Diseases Physician Infusion Centers

Evaluation of Bezlotoxumab in Prevention of Recurrent C. Difficile Infection: A multicenter Single-Arm Study in Office Infusion Centers

Healthcare Resource Utilization for High-Risk Patients Treated with Dalbavancin in Physician Office Infusion Centers

Predictors of Vedolizumab Treatment Persistence in Bio-Naïve Ulcerative Colitis Patients

Real-World Prescribing Patterns of Certolizumab in the Treatment of Crohn’s Disease

Long-Term Efficacy of Vedolizumab in Pediatric Inflammatory Bowel Disease

Onset of Response with Infliximab vs. Vedolizumab in the Treatment of Bio-Naïve Inflammatory Bowel Disease

Second-Line Biologic Therapy After Vedolizumab

Use of Ustekinumab in Pediatric Crohn’s Disease – A Report of Three Cases

Response and Healthcare Resource Utilization in Inflammatory Bowel Disease Patients Treated with Either Infliximab or Vedolizumab

Low 30-Day Hospital Readmission Rates in Medicare Patients Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT) in Physician Office Infusion Centers

Serious Bacterial Infections: Successful Outpatient Management by Infectious Disease Physicians in Office Infusion Centers

Recurrent Clostridioides Difficile Infection (CDI) Worsens Anxiety-Related Patient-Reported Quality of Life

Real-World Use of Ibalizumab in Physician Office infusion Centers (POICs)

Application of Bayesian Modeling with Infliximab to Determine Optimal Patient Specific Regimen

Tolerability and Persistence with Subcutaneous Immunoglobulin Provided Through Physician Clinics for the Treatment of Primary Immunodeficiencies

Failure of Vedolizumab as First Line Biologic Does Not Decrease Response Rate of Second Line Therapy

Therapeutic Drug Monitoring of Biologics in patients with Inflammatory Bowel Disease: A Real-World Experience

Mandated Payor Switching with Infliximab (IFX) Bioimilars

Healthcare Resource Utilization in Inflammatory Bowel Disease Patients: A 2-Year Analysis

Infection Incidence and Utilization of Antimicrobials in Physician Office Infusion Centers (POICs)

Real World Experience of Bezlotoxumab for Prevention of Recurrent C. Difficile Infection: A Single-Arm Multicenter Pilot Study in Office Infusion Centers

Real World Evaluation of Prolonged Clinical Response with Vedolizumab in Crohn’s Disease and Ulcerative Colitis patients Treated in a Private Practice Setting

Long-Term Safety Analysis of Vedolizumab for Treatment of Crohn’s Disease and Ulcerative Colitis

Can Vedolizumab Non-Responders Be Treated Successfully with Another Biologic Agent?

Successful Establishment of an Antimicrobial Stewardship Program (ASP) for Outpatient Parenteral Antimicrobial Therapy (OPAT)

Clinical and Economic Outcomes of Outpatient Parenteral Antimicrobial Therapy (OPAT) Among Indigent Patients: A Retrospective Multicenter Analysis

Outpatient Treatment of Infective Endocarditis (IE) at Physician Office Infusion Centers (POICs): A 2-Year Analysis of Clinical and Economic Outcomes

Ceftolozane/Tazobactam: Outpatient Treatment of Gram-Negative Infections at Physician Office Infusion Centers (POICs)

Successful Early Discharge and Avoided Hospitalization for Methicillin-Resistant Staphylococcus aureus Infections Treated With Outpatient Parenteral Antimicrobial Therapy Result in Healthcare Cost Savings

Successful Management of Osteomyelitis in Infectious Disease Physician Office Infusion Centers (POICs)

Antimicrobial Regimen and Safety of Pediatric Outpatient Treatment in a Physician Office Infusion Center (POIC)

Antimicrobial Regimen and Safety of Pediatric Outpatient Treatment in a Physician Office Infusion Center (POIC)

Dalbavancin: A Nationwide Outpatient Experience in Physician Office Infusion Centers (POICs)

Low Hospital Admission Rates Following Physician Office Infusion Center (POIC)-Based Outpatient Treatment with Intravenous Antibiotics

Outpatient Parenteral Antimicrobial Therapy (OPAT) for Treatment of Complicated Intra-Abdominal Infections

Vancomycin Experience in Physician Office Infusion Centers

Clinical Success in Outpatient Treatment of Complicated Urinary Tract Infections (UTI) with Ertapenem

Clostridium difficile-Associated Diarrhea Incidence and Outcomes for Patients Treated with Intravenous Antibiotics in Infectious Disease Physician Office Infusion Centers (POICs)

Comparison of Outcomes and Costs in Patients with Urinary Tract Infections (UTI) or Pneumonia (PNA) with Treatment Initiated in a Physician Office Infusion Center (POIC) versus Those Treated After Hospital Discharge

Utilization of Intravenous Antimicrobials over a One-Year Period in Physician Office Infusion Centers (POICs)

Successful, Cost-Saving Outpatient Parenteral Antimicrobial Therapy (OPAT) Following Hospital Discharge: Early Pilot Study of an Indigent Healthcare Program between a Physician Office Infusion Center (POIC) and Two Tucson Hospitals

Outcomes Comparison of Intravenous Antimicrobials Provided in a Physician Office Infusion Center (POIC) versus Traditional Home Care (HC) Services

Incidence of Central Venous Catheter (CVC) Infections in Patients Treated with Intravenous Antibiotics (IVAB) in the Physician Office Infusion Center (POIC)

Outcomes and Readmissions of Bacteremia, Endocarditis and Osteomyelitis among Patients Treated with Outpatient Parenteral Antimicrobial Therapy (OPAT) in Infectious Disease Physician Office Infusion Centers (POIC)

Clostridium difficile Associated Diarrhea Incidence and Outcomes for Patients Treated with Intravenous Antibiotics in Infectious Disease Physician Office Infusion Centers

Successful, Cost-Saving OPAT Therapy Initiated in a Physician Office Infusion Center (POIC) for Treatment of Osteomyelitis and Complicated Skin and Skin Structure Infections, a 3-Year Analysis

Outpatient Parenteral Antibiotic Therapy (OPAT) with Telavancin: A Multi-Center Experience

Clinical Success Demonstrated in Treatment of Complicated Genitourinary Gram Negative Infections in a Physician Office Infusion Center (POIC)

Successful Treatment of Complicated Gram Negative Sinopulmonary Infections Treated in Infectious Disease (ID) Physician Office Infusion Centers (POICs)

Infection Control Enhancements through Successful Implementation of United States Pharmacopeia Chapter <797> Standards (USP 797) in a Physician Infusion Center Pharmacy

Safety, Efficacy and Cost-Benefit of Initiating Treatment of Osteomyelitis and Complicated Skin and Skin Structure Infections in a Physician Office-Based Infusion Center, A Two-Year Review

Treatment of Osteomyelitis in Infectious Disease Physician-Operated Infusion Centers (POICs)

Safety and Efficacy of Direct Physician Office-Based Infusion Center (POIC) Admissions for Antibiotic Treatment of Osteomyelitis (OSTEO) and Complicated Skin and Skin Structure Infections (cSSSI)

Parenteral Antimicrobial Therapy Initiated in the Infectious Disease (ID) Physician Office: What and Why?

Comparison of Outpatient Antibiotic Therapy (OPAT) Use of Daptomycin, Linezolid, Quinupristin/Dalfopristin, Tigecycline, and Vancomycin in Physician-Operated Infusion Centers (POICs)

Phase II and Phase III Studies